NCT02357719View on ClinicalTrials.gov

Effectiveness of VistaO2 FLUX Device in Screening of Sleep Apnea/Hypopnea Syndrome

NATerminatedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

March 5, 2015

Primary Completion Date

May 31, 2017

Study Completion Date

June 2, 2017

Conditions
Sleep Apnea Syndromes
Interventions
DEVICE

VistaO2 FLUX device

Full night VistaO2 FLUX device monitoring synchronized with the gold standard polysomnography.

Trial Locations (2)

42055

CHU de Saint-Etienne, Saint-Etienne

75000

Hopital Pitié Salpetrière - APHP, Paris

Sponsors

Collaborators (1)

Novacor
All Listed Sponsors
collaborator

Novacor

UNKNOWN

lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER